VOLPE, Gisella
VOLPE, Gisella
SCIENZE CLINICHE E BIOLOGICHE
A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis
2013-01-01 C Panuzzo; S Crivellaro; C Casnici; E Cibrario; F Crasto; R Lorenzatti; F Daraio; K Crotta; G Carrà; A Morotti; G saglio; G Volpe
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches
2007-01-01 VOLPE G; CIGNETTI A; PANUZZO C; KUKA M; VITAGGIO K; BRANCACCIO M; PERRONE G; RINALDI M; PRATO G; FAVA M; GEUNA M; PAUTASSO M; CASNICI C; SIGNORI E; TONON G; TARONE G; MARELLI O; FAZIO VM; SAGLIO G
Analysis of microsatellite instability in chronic lymphoproliferative disorders
1996-01-01 Volpe, G; Gamberi, B; Pastore, C; Roetto, A; Pautasso, M; Parvis, G; Camaschella, C; Mazza, U; Saglio, G; Gaidano, G
Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins.
2011-01-01 Casnici C; Volpe G; Crotta K; Panuzzo C; Lattuada D; Cabras CA; Longhi R; Saglio G; Marelli O.
Imatinib resistance in CML
2009-01-01 Volpe G; Panuzzo C; Ulisciani S; Cilloni D.
Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice
2012-01-01 Casnici C; Volpe G; Crotta K; Lattuada D; Saglio G; Marelli O.
Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report.
2015-01-01 Roggero S; Vullo S; Volpe G; Piga A; Albera C
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA.
2015-01-01 C. Panuzzo, G. Volpe, E. Cibrario Rocchietti, C. Casnici, K. Crotta, S. Crivellaro, G. Carrà, F. Daraio, R. Lorenzatti, D. Torti, A. Morotti,O. Marelli, G. Saglio
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia
2015-01-01 Panuzzo, Cristina; Volpe, Gisella; Cibrario Rocchietti, Elisa; Casnici, Claudia; Crotta, Katia; Crivellaro, Sabrina; Carrà, Giovanna; Lorenzatti, Roberta; Peracino, Barbara; Torti, Davide; Morotti, Alessandro; Camacho-Leal, Maria Pilar; Defilippi, Paola; Marelli, Ornella; Saglio, Giuseppe
New perspectives for molecular targeted therapy in human leukemias
2002-01-01 G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio
Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice
2009-01-01 Casnici C; Volpe G; Lattuada D; Crotta K; Kuka M; Panuzzo C; Mastrotto C; Tonon G; Fazio VM; Saglio G; Marelli O.
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
2002-01-01 CILLONI D; GOTTARDI E; DE MICHELI D; SERRA A; VOLPE G; MESSA F; REGE-CAMBRIN G; GUERRASIO A; DIVONA A; LO COCO F; G. SAGLIO
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia
2004-01-01 SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D.
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients
2017-01-01 Casnici, Claudia; Crotta, Katia; Volpe, Gisella; Panuzzo, Cristina; Lattuada, Donatella; Mesiano, Giulia; Saglio, Giuseppe; Marelli, Ornella
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy
2016-01-01 Gallo, Daniela; Nicoli, Paolo; Calabrese, Chiara; Gaidano, Valentina; Petiti, Jessica; Rosso, Valentina; Signorino, Elisabetta; Carturan, Sonia; Bot-Sartor, Giada; Volpe, Gisella; Frassoni, Francesco; Saglio, Giuseppe; Cilloni, Daniela
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis | 2013 | C Panuzzo; S Crivellaro; C Casnici; E Cibrario; F Crasto; R Lorenzatti; F Daraio; K Crotta; G Carrà; A Morotti; G saglio; G Volpe | |
| Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches | 2007 | VOLPE G; CIGNETTI A; PANUZZO C; KUKA M; VITAGGIO K; BRANCACCIO M; PERRONE G; RINALDI M; PRATO G; FAVA M; GEUNA M; PAUTASSO M; CASNICI C; SIGNORI E; TONON G; TARONE G; MARELLI O; FAZIO VM; SAGLIO G | |
| Analysis of microsatellite instability in chronic lymphoproliferative disorders | 1996 | Volpe, G; Gamberi, B; Pastore, C; Roetto, A; Pautasso, M; Parvis, G; Camaschella, C; Mazza, U; Saglio, G; Gaidano, G | |
| Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins. | 2011 | Casnici C; Volpe G; Crotta K; Panuzzo C; Lattuada D; Cabras CA; Longhi R; Saglio G; Marelli O. | |
| Imatinib resistance in CML | 2009 | Volpe G; Panuzzo C; Ulisciani S; Cilloni D. | |
| Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice | 2012 | Casnici C; Volpe G; Crotta K; Lattuada D; Saglio G; Marelli O. | |
| Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report. | 2015 | Roggero S; Vullo S; Volpe G; Piga A; Albera C | |
| NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. | 2015 | C. Panuzzo, G. Volpe, E. Cibrario Rocchietti, C. Casnici, K. Crotta, S. Crivellaro, G. Carrà, F. Daraio, R. Lorenzatti, D. Torti, A. Morotti,O. Marelli, G. Saglio | |
| New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia | 2015 | Panuzzo, Cristina; Volpe, Gisella; Cibrario Rocchietti, Elisa; Casnici, Claudia; Crotta, Katia; Crivellaro, Sabrina; Carrà, Giovanna; Lorenzatti, Roberta; Peracino, Barbara; Torti, Davide; Morotti, Alessandro; Camacho-Leal, Maria Pilar; Defilippi, Paola; Marelli, Ornella; Saglio, Giuseppe | |
| New perspectives for molecular targeted therapy in human leukemias | 2002 | G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio | |
| Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice | 2009 | Casnici C; Volpe G; Lattuada D; Crotta K; Kuka M; Panuzzo C; Mastrotto C; Tonon G; Fazio VM; Saglio G; Marelli O. | |
| Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients | 2002 | CILLONI D; GOTTARDI E; DE MICHELI D; SERRA A; VOLPE G; MESSA F; REGE-CAMBRIN G; GUERRASIO A; DIVONA A; LO COCO F; G. SAGLIO | |
| Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia | 2004 | SAGLIO G; MOROTTI A; MATTIOLI G; MESSA E; GIUGLIANO E; VOLPE G; REGE-CAMBRIN; G; CILLONI D. | |
| Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients | 2017 | Casnici, Claudia; Crotta, Katia; Volpe, Gisella; Panuzzo, Cristina; Lattuada, Donatella; Mesiano, Giulia; Saglio, Giuseppe; Marelli, Ornella | |
| The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy | 2016 | Gallo, Daniela; Nicoli, Paolo; Calabrese, Chiara; Gaidano, Valentina; Petiti, Jessica; Rosso, Valentina; Signorino, Elisabetta; Carturan, Sonia; Bot-Sartor, Giada; Volpe, Gisella; Frassoni, Francesco; Saglio, Giuseppe; Cilloni, Daniela |